InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.00%
)
US TECH 100
16,804.40
(
-1.50%
)
Dow Jones
38,460.92
(
0.00%
)
Brent Oil
86.56
(
-0.76%
)
Bitcoin
63,035.68
(
-1.94%
)
Post# of 113
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

instock58

Send PM Follow Ignore
Followers 125
Posts 8753
Boards Moderated 3
Alias Born 05/25/2015

instock58

Re: None

Wednesday, 04/01/2020 12:17:43 PM

Wednesday, April 01, 2020 12:17:43 PM

Post# of 113
DFFN UP 62%, Dip Buy opportunity here. Current.52 , Yahoo Target $3.50 , 48X Normal Volume

Lunch BUYERS in about 30 MIns will drive price higher

" Diffusion Pharmaceuticals Evaluating TSC Against Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients"

" CHARLOTTESVILLE, Va., April 01, 2020 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (DFFN) (“Diffusion” or “the Company”), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to deliver oxygen to the areas where it is needed most, "


https://finance.yahoo.com/news/diffusion-pharmaceuticals-evaluating-tsc-against-120010293.html

https://ih.advfn.com/stock-market/NASDAQ/diffusion-pharmaceuticals-DFFN/stock-news/82139647/diffusion-pharmaceuticals-evaluating-tsc-against-a


$DFFN
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up